Exact Mass: 598.1264

Exact Mass Matches: 598.1264

Found 84 metabolites which its exact mass value is equals to given mass value 598.1264, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-(Hydrocinchonidin-8-yl)-4-azido-2-hydroxybenzamide

IACI; N-(Hydrocinchonidin-8-yl)-4-azido-2-hydroxybenzamide

C26H27IN6O3 (598.1189)

Dexamethazone metasulfobenzoate sodium

C29H32FO9S. Na (598.1649)

Same as: D01510

Fusaroskyrin

1,4,5-trihydroxy-7-methoxy-2-methyl-8-(4,5,8-trihydroxy-2-methoxy-7-methyl-9,10-dioxo-9,10-dihydroanthracen-1-yl)-9,10-dihydroanthracene-9,10-dione

C32H22O12 (598.1111)

Responsible for purple speck disease in soybean Responsible for purple speck disease in soybea

Glabraoside B

C30H30O13 (598.1686)

Yunnaneic acid F

(+)-Yunnaneic acid F

C29H26O14 (598.1322)

(2S)-6,8-dimethyl-5,7,2,5-tetrahydroflavanone 7-O-(6-O-p-hydroxybenzoyl)-beta-D-glucopyranoside|myrciacitrin V

C30H30O13 (598.1686)

NSC374707

C32H22O12 (598.1111)

6,6-Bierythroglaucin

C32H22O12 (598.1111)

1-O-[beta?D-xylopyranosyl-(1?6)-beta?D-glucopyranosyl]-3,8-dihydroxy-4,5-dimethoxyxanthone

C26H30O16 (598.1534)

3,3,4,5,9,10-hexahydroxy-12-methylchroman[2,3-h]flavone 3-O-beta-D-glucopyranoside|lactucasativoside A

C29H26O14 (598.1322)

3-O-[beta-D-xylopyranosyl-(1?6)-beta-D-glucopyranosyl]-1,8-dihydroxy-4,5-dimethoxyxanthone|kouitchenside F

C26H30O16 (598.1534)

swertiapuniside

C26H30O16 (598.1534)

Quercetin 3-O-sambubioside

C26H30O16 (598.1534)

3-methoxy-7-O-beta-(6-galloylglucopyranoside)kaempferol

C29H26O14 (598.1322)

glabraoside C

C30H30O13 (598.1686)

C26H30O16

C26H30O16 (598.1534)

tricetin 6,8-di-C-alpha-L-arabinopyranoside

C25H26O17 (598.117)

HV-1

C32H22O12 (598.1111)

Jacaranose

C30H30O13 (598.1686)

3,8-biisokaempferide

C32H22O12 (598.1111)

{3,4,5-triacetyloxy-6-[3-(4-methoxyphenyl)-4-oxochromen-6-yloxy]-2H-3,4,5,6-te trahydropyran-2-yl}methyl acetate

C30H30O13 (598.1686)

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.356 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.355

[(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy-6-[[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxymethyl]oxan-3-yl] 2-phenylacetate

NCGC00347589-02![(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy-6-[[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxymethyl]oxan-3-yl] 2-phenylacetate

C30H30O13 (598.1686)

JACAGLABROSIDE B_40.5\\%

C30H30O13 (598.1686)

JACAGLABROSIDE B_major

C30H30O13 (598.1686)

JACAGLABROSIDE B_74.3\\%

C30H30O13 (598.1686)

Fusaroskyrin

1,4,5-trihydroxy-7-methoxy-2-methyl-8-(4,5,8-trihydroxy-2-methoxy-7-methyl-9,10-dioxo-9,10-dihydroanthracen-1-yl)-9,10-dihydroanthracene-9,10-dione

C32H22O12 (598.1111)

KN-93 Phosphate

C26H32ClN2O8PS (598.1305)

1,3-bis(2,4,6-trimethylphenyl)imidazolidin-2-ide,dichloro(3-pyridin-2-ylpropylidene)ruthenium

C29H36Cl2N3Ru (598.133)

(s)-(+)-1,1-bi-2-naphthyl di-p-toluenesulfonate

C34H30O6S2 (598.1484)

GALLIUM(III) PHTHALOCYANINE HYDROXIDE

C32H17GaN8O (598.0781)

Adenosylmethionine 1,4-butanedisulfonate

C19H30N6O10S3 (598.1185)

N-[(1S)-1-[[(6S)-6-[5-(7-BROMO-9,9-DIFLUORO-9H-FLUOREN-2-YL)-1H-IMIDAZOL-2-YL]-5-AZASPIRO[2.4]HEPT-5-YL]CARBONYL]-2-METHYLPROPYL]CARBAMIC ACID METHYL ESTER

C29H29BrF2N4O3 (598.1391)

N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-1-methyl-2,3-dioxopiperidine-4-carboxamide

C31H27ClN6O5 (598.1731)

(R)-(-)-2,2-Bis(p-toluenesulfonyloxy)-1,1-binaphthalene

C34H30O6S2 (598.1484)

1,2-BIS(DICYCLOHEXYLPHOSPHINO)ETHANE]PALLADIUM(II) CHLORIDE

C26H48Cl2P2Pd (598.1643)

Dexamethazone metasulfobenzoate sodium

C29H32FNaO9S (598.1649)

Myrciacitrin V

C30H30O13 (598.1686)

A flavanone glycoside that is (2S)-flavanone substituted by hydroxy groups at positions 5, 2 and 5, methyl groups at positions 6 and 8 and a (6-O-p-hydroxybenzoyl)-beta-D-glucopyranosyloxy residue at position 7. Isolated from the leaves of Myrcia multiflora, it exhibits inhibitory activity against aldose reductase.

8-[5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-8-yl]-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one

C32H22O12 (598.1111)

IACI

N-(Hydrocinchonidin-8-yl)-4-azido-2-hydroxybenzamide

C26H27IN6O3 (598.1189)

IACS-010759 (hydrochloride)

C25H26ClF3N6O4S (598.1377)

IACS-010759 hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia (AML) reliant on OXPHOS. IACS-010759 hydrochloride has the potential for relapsed/refractory AML and solid tumors research[1][2].

4,5-bis(acetyloxy)-2-methoxy-3-[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]benzoic acid

C26H30O16 (598.1534)

(6-{[2-(2,5-dihydroxyphenyl)-5-hydroxy-6,8-dimethyl-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 4-hydroxybenzoate

C30H30O13 (598.1686)

4-{[4-(acetyloxy)-2,9,10-trihydroxy-8-(5-hydroxy-6-methyloxan-2-yl)-2-methyl-1,5-dioxo-3h,4h-benzo[b]fluoren-3-yl]oxy}-4-oxobutanoic acid

C30H30O13 (598.1686)

13,21-dihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2(11),4,6,8,17,20,22,24,27-decaene-3,10,15,19,26-pentone

C33H26O11 (598.1475)

1,8-dihydroxy-5,6-dimethoxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}xanthen-9-one

C26H30O16 (598.1534)

7,8,19,20,27-pentahydroxy-1,25-dimethyl-11-oxo-4,16,24,28,29-pentaoxaoctacyclo[23.3.1.0²,²³.0³,¹².0⁵,¹⁰.0¹⁴,²³.0¹⁴,²⁷.0¹⁷,²²]nonacosa-3(12),5,7,9,17,19,21-heptaene-9,21-dicarboxylic acid

7,8,19,20,27-pentahydroxy-1,25-dimethyl-11-oxo-4,16,24,28,29-pentaoxaoctacyclo[23.3.1.0²,²³.0³,¹².0⁵,¹⁰.0¹⁴,²³.0¹⁴,²⁷.0¹⁷,²²]nonacosa-3(12),5,7,9,17,19,21-heptaene-9,21-dicarboxylic acid

C28H22O15 (598.0959)

4,5-dihydroxy-1,2-dimethoxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}xanthen-9-one

C26H30O16 (598.1534)

6-[(3,4-dihydroxy-2-methoxyphenyl)methyl]-7-(3,4-dihydroxyphenyl)-2,10-dihydroxy-9,11-dimethoxy-5-oxatetraphen-3-one

C33H26O11 (598.1475)

(1r,2s,6s,7r,8r,9r)-10-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-8-(3,4-dihydroxyphenyl)-2,6-dihydroxy-4-oxo-3-oxatricyclo[5.2.2.0²,⁶]undec-10-ene-9-carboxylic acid

(1r,2s,6s,7r,8r,9r)-10-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-8-(3,4-dihydroxyphenyl)-2,6-dihydroxy-4-oxo-3-oxatricyclo[5.2.2.0²,⁶]undec-10-ene-9-carboxylic acid

C29H26O14 (598.1322)

1-{2,4-dihydroxy-3-[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl}-2-{2,4-dihydroxy-3-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl}ethane-1,2-dione

C26H30O16 (598.1534)

5,6,8-trihydroxy-2-(2-oxopropyl)-9-[5,6,8-trihydroxy-4-oxo-2-(2-oxopropyl)benzo[g]chromen-9-yl]benzo[g]chromen-4-one

C32H22O12 (598.1111)

methyl 4-(2-{2-[2,6-dihydroxy-4-(methoxycarbonyl)benzoyl]-3-hydroxyphenyl}-7-hydroxy-3-oxoinden-1-yl)-3,5-dihydroxybenzoate

C32H22O12 (598.1111)

1,8-dihydroxy-4,5-dimethoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}xanthen-9-one

C26H30O16 (598.1534)

(4r,5s,14s)-4,14-bis(3,4-dihydroxyphenyl)-8-hydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-12-one

C30H30O13 (598.1686)

8-[5-(5,7-dihydroxy-3-methoxy-4-oxochromen-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-3-methoxychromen-4-one

C32H22O12 (598.1111)

(13s)-13,21-dihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2(11),4,6,8,17,20,22,24,27-decaene-3,10,15,19,26-pentone

C33H26O11 (598.1475)

crisamicin a

C32H22O12 (598.1111)

4,5-dihydroxy-1,2-dimethoxy-6-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]xanthen-9-one

C26H30O16 (598.1534)

10-{3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl}-8-(3,4-dihydroxyphenyl)-2,6-dihydroxy-4-oxo-3-oxatricyclo[5.2.2.0²,⁶]undec-10-ene-9-carboxylic acid

C29H26O14 (598.1322)

(13r)-13,21-dihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2(11),4,6,8,17,20,22,24,27-decaene-3,10,15,19,26-pentone

C33H26O11 (598.1475)

2-{[5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl 3,4,5-trihydroxybenzoate

C29H26O14 (598.1322)

2-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl 3,5-dihydroxy-4-methoxybenzoate

C29H26O14 (598.1322)

4,5-bis(acetyloxy)-2-methoxy-3-[(2r,3s,4r,5r,6r)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]benzoic acid

C26H30O16 (598.1534)

(2s,3r,4r,5s,6s)-2-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl 3,5-dihydroxy-4-methoxybenzoate

C29H26O14 (598.1322)

(2s)-7,9-dihydroxy-12-methoxy-2-methyl-2-[(1e)-2-(1,3,5-trihydroxy-9-oxoxanthen-2-yl)ethenyl]-3h-1,4,5-trioxatetraphen-10-one

C32H22O12 (598.1111)

4-{[(2s,3r,4s)-4-(acetyloxy)-2,9,10-trihydroxy-8-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]-2-methyl-1,5-dioxo-3h,4h-benzo[b]fluoren-3-yl]oxy}-4-oxobutanoic acid

C30H30O13 (598.1686)

bis({2,4-dihydroxy-3-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl})ethane-1,2-dione

C26H30O16 (598.1534)

[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-{[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy}-5-[(2-phenylacetyl)oxy]oxan-2-yl]methyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate

C30H30O13 (598.1686)

bis({2,4-dihydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl})ethane-1,2-dione

C26H30O16 (598.1534)

7-hydroxy-5-{7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl}-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

7-hydroxy-5-{7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl}-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

C32H22O12 (598.1111)

1,8-dihydroxy-5,6-dimethoxy-2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]xanthen-9-one

C26H30O16 (598.1534)

(3s,4s,6s)-10,13-dihydroxy-6-methyl-3-{1,6,7-trihydroxy-3-methyl-11-oxobenzo[a]fluoren-5-yl}-5-oxapentacyclo[9.7.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(11),2(8),9,12,14,16-hexaene-7,18-dione

C36H22O9 (598.1264)

(4r,5s,14r)-4,14-bis(3,4-dihydroxyphenyl)-8-hydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-12-one

C30H30O13 (598.1686)

(1r,2s,6s,7r,8s,9r)-10-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-8-(3,4-dihydroxyphenyl)-2,6-dihydroxy-4-oxo-3-oxatricyclo[5.2.2.0²,⁶]undec-10-ene-9-carboxylic acid

(1r,2s,6s,7r,8s,9r)-10-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-8-(3,4-dihydroxyphenyl)-2,6-dihydroxy-4-oxo-3-oxatricyclo[5.2.2.0²,⁶]undec-10-ene-9-carboxylic acid

C29H26O14 (598.1322)

7,9-dihydroxy-12-methoxy-2-methyl-2-[2-(1,3,5-trihydroxy-9-oxoxanthen-2-yl)ethenyl]-3h-1,4,5-trioxatetraphen-10-one

C32H22O12 (598.1111)

4,14-bis(3,4-dihydroxyphenyl)-8-hydroxy-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-12-one

C30H30O13 (598.1686)

6-[(3,4-dihydroxy-2-methoxyphenyl)methyl]-8-(3,4-dihydroxyphenyl)-2,10-dihydroxy-9,11-dimethoxy-5-oxatetraphen-3-one

C33H26O11 (598.1475)